April 1, 2026 - 07:33

Subprime lender Goeasy Ltd. has indicated that higher-than-normal loan losses are expected to persist in the near term, following a recent surge in bad debts within its vehicle financing division that caught the market off guard.
The company stated that write-off levels are likely to remain elevated for a period before conditions begin to improve later in the year. This forecast points to ongoing pressure on consumers with weaker credit scores, who are increasingly struggling to meet payment obligations amid sustained economic challenges.
Management expressed confidence in their portfolio's underlying fundamentals and their proactive risk management strategies. They emphasized that the current difficulties are viewed as a cyclical phase rather than a long-term deterioration in their business model. The company's provisions for credit losses have been adjusted to reflect the tougher environment.
Analysts are monitoring the situation closely, as the performance of subprime lenders is often seen as an early indicator of broader financial stress among consumers. Goeasy's outlook suggests that while the immediate future may hold challenges, a recovery path is anticipated as the year progresses. The company continues to focus on serving its core market, which often lacks access to traditional banking services.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...